OnTheIssuesLogo

Steve Bullock on Drugs

Democratic Presidential Challenger (withdrawn); MT Governor

 


Let the states decide on legalizing marijuana

Bullock on Legalizing Marijuana: Let the states decide.

TWO CANDIDATES HAVE SIMILAR VIEWS: John Delaney; Wayne Messam.

The federal government has generally taken a hands-off approach to enforcing federal marijuana laws in states that have authorized medical or recreational markets. But that informal policy could be reversed by any administration at any moment. That's why some candidates have endorsed allowing state-legal markets to operate without fear of punishment from the federal government.

Source: Politico "2020Dems on the Issues" , Jul 17, 2019

Strongly supports medical marijuana

Source: Cannabis Voter Project report on 2020 candidates , Jul 2, 2019

Confront the invisible epidemic of prescription drug abuse

Since taking office as Attorney General, Steve has:
Source: Montana Governor campaign 2012 website, www.stevebullock.com , Nov 6, 2012

Rated B- by NORML, indicating a pro-drug-reform stance.

Bullock scores B- by the NORML on drug reform

OnTheIssues.org interprets the 2016 NORML scores as follows:

About NORML (from their website, www.norml.org):

National Organization for the Reform of Marijuana Law's mission is to move public opinion sufficiently to achieve the repeal of marijuana prohibition so that the responsible use of cannabis by adults is no longer subject to penalty.

NORML is a nonprofit, public-interest lobby that for more than 30 years has provided a voice for those Americans who oppose marijuana prohibition. We represent the interests of the tens of millions of Americans who smoke marijuana responsibly and believe the recreational and medicinal use of marijuana should no longer be a crime.

NORML supports the removal of all criminal penalties for the private possession & responsible use of marijuana by adults, including the cultivation for personal use, and the casual nonprofit transfers of small amounts. This model is called "decriminalization."

NORML additionally supports the development of a legally controlled market for marijuana, where consumers could purchase it from a safe, legal and regulated source. This model is referred to as "legalization."

NORML believes that marijuana smoking is not for kids and should only be used responsibly by adults. As with alcohol consumption, it must never be an excuse for misconduct or other bad behavior. Driving or operating heavy equipment while impaired from marijuana should be prohibited.

NORML strongly supports the right of patients to use marijuana as a medicine when their physician recommends it to relieve pain and suffering.

Lastly, NORML supports the right of farmers to commercially cultivate hemp for industrial purposes, such as food and fiber production.

Source: NORML website 16_NORML on Nov 8, 2016

Other candidates on Drugs: Steve Bullock on other issues:
MT Gubernatorial:
Albert Olszewski
Brian Schweitzer
Casey Schreiner
Corey Stapleton
Gary Perry
Greg Gianforte
Mike Cooney
Reilly Neill
Tim Fox
Whitney Williams
MT Senatorial:
Albert Olszewski
John Driscoll
John Mues
Jon Tester
Matt Rosendale
Mike Cooney
Steve Daines
Susan Good Geise
Wilmot Collins

MT politicians
MT Archives
Senate races 2019-20:
AK: Sullivan(R,incumbent) vs.Gross(I) vs.Blatchford(D)
AL: Jones(D,incumbent) vs.Tuberville(R) vs.Sessions(R) vs.Moore(R) vs.Rogers(D) vs.Merrill(R)
AR: Cotton(R,incumbent) vs.Harrington(L) vs.Whitfield(I) vs.Mahony(D)
AZ: McSally(R,incumbent) vs.Kelly(D)
CO: Gardner(R,incumbent) vs.Hickenlooper(D) vs.Madden(D) vs.Baer(D) vs.Walsh(D) vs.Johnston(D) vs.Romanoff(D) vs.Burnes(D) vs.Williams(D)
DE: Coons(D,incumbent) vs.Scarane(D) vs.Witzke(R) vs.DeMartino(R)
GA-2: Isakson(R,resigned) Loeffler(R,appointed) vs.Warnock(D) vs.Collins(R) vs.Tarver(D) vs.Carter(D) vs.Lieberman(D) vs.Grayson(R) vs.Stovall(I) vs.Buckley(L)
GA-6: Perdue(R,incumbent) vs.Ossoff(D) vs.Hazel(L) vs.Tomlinson(D) vs.Terry(D)
IA: Ernst(R,incumbent) vs.Greenfield(D) vs.Graham(D) vs.Mauro(D) vs.Franken(D)
ID: Risch(R,incumbent) vs.Jordan(D) vs.Harris(D)
IL: Durbin(D,incumbent) vs.Curran(R) vs.Stava-Murray(D)
KS: Roberts(R,retiring) vs.Marshall(R) vs.Bollier(D) vs.LaTurner(R) vs.Wagle(R) vs.Kobach(R) vs.Lindstrom(R) vs.Grissom(D)
KY: McConnell(R,incumbent) vs.McGrath(D) vs.Morgan(R) vs.Cox(D) vs.Tobin(D) vs.Booker(D)
LA: Cassidy(R,incumbent) vs.Perkins(D) vs.Pierce(D)

MA: Markey(D,incumbent) vs.O`Connor(R) vs.Ayyadurai(R) vs.Kennedy(D) vs.Liss-Riordan(D)
ME: Collins(R,incumbent) vs.Gideon(D) vs.Sweet(D) vs.Rice(D)
MI: Peters(D,incumbent) vs.James(R) vs.Squier(G)
MN: Smith(D,incumbent) vs.Lewis(R) vs.Overby(G) vs.Carlson(D)
MS: Hyde-Smith(R,incumbent) vs.Espy(D) vs.Bohren(D)
MT: Daines(R,incumbent) vs.Bullock(D) vs.Collins(D) vs.Driscoll(R) vs.Mues(D) vs.Geise(L)
NC: Tillis(R,incumbent) vs.Cunningham(D) vs.E.Smith(D) vs.S.Smith(R) vs.Tucker(R) vs.Mansfield(D)
NE: Sasse(R,incumbent) vs.Janicek(R)
NH: Shaheen(D,incumbent) vs.Messner(R) vs.Martin(D) vs.Bolduc(R) vs.O'Brien(R)
NJ: Booker(D,incumbent) vs.Mehta(R) vs.Singh(R) vs.Meissner(R)
NM: Udall(D,retiring) vs.Lujan(D) vs.Ronchetti(R) vs.Walsh(L) vs.Clarkson(R) vs.Oliver(D) vs.Rich(R)
OK: Inhofe(R,incumbent) vs.Broyles(D) vs.Workman(D)
OR: Merkley(D,incumbent) vs.Perkins(R) vs.Romero(R)
RI: Reed(D,incumbent) vs.Waters(R)
SC: Graham(R,incumbent) vs.Harrison(D) vs.Tinubu(D)
SD: Rounds(R,incumbent) vs.Ahlers(D) vs.Borglum(R)
TN: Alexander(R,retiring) vs.Hagerty(R) vs.Bradshaw(D) vs.Sethi(R) vs.Mackler(D) vs.Crim(R)
TX: Cornyn(R,incumbent) vs.Hegar(D) vs.Hernandez(D) vs.Bell(D) vs.Ramirez(D) vs.West(D)
VA: Warner(D,incumbent) vs.Taylor(R) vs.Gade(R)
WV: Capito(R,incumbent) vs.Swearengin(D) vs.Ojeda(D)
WY: Enzi(R,retiring) vs.Lummis(R) vs.Ben-David(D) vs.Ludwig(D)
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare

Other Senators
Senate Votes (analysis)
Bill Sponsorships
Affiliations
Policy Reports
Group Ratings
 





Page last updated: Dec 06, 2020